Trials / Completed
CompletedNCT05448248
Multicenter Registry Study Of Cerebral Venous Thrombosis In China (RETAIN-CH)
A Registry Study of Cerebral Venous Sinus Thrombosis in China
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,276 (actual)
- Sponsor
- Capital Medical University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This study will investigate the epidemiology, risk factors, diagnostics, treatment, and the long-term prognosis of cerebral venous thrombosis in China.
Detailed description
The epidemiology, risk factors, diagnosis and treatment of Cerebral Venous Thrombosis (CVT) in China are still unclear. A retrospective hospital-based study will be conducted at fifty different hospitals across 31 provinces in China. This study will use ICD-10 to search patients diagnosed with CVT between January 1, 2018 and June 15, 2022 across 31 provinces and municipalities of 104 hospitals in China. Risk factors, clinical and radiological findings, treatment and short-term outcomes will be recorded from the hospital record system. Finally, a prospective follow-up will be conducted for all of the patients enrolled above. By combining data collected from retrospective hospital records with the new follow-up, it will be possible to better understand the epidemiology, risk factors, diagnosis, treatment and the long-term prognosis of CVT in China.
Conditions
Timeline
- Start date
- 2022-08-20
- Primary completion
- 2023-12-20
- Completion
- 2023-12-20
- First posted
- 2022-07-07
- Last updated
- 2024-02-26
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05448248. Inclusion in this directory is not an endorsement.